1. Home
  2. TCI vs TENX Comparison

TCI vs TENX Comparison

Compare TCI & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transcontinental Realty Investors Inc.

TCI

Transcontinental Realty Investors Inc.

N/A

Current Price

$41.18

Market Cap

349.1M

Sector

Finance

ML Signal

N/A

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$14.53

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCI
TENX
Founded
1983
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.1M
317.8M
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
TCI
TENX
Price
$41.18
$14.53
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$29.67
AVG Volume (30 Days)
3.7K
1.4M
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
135.29
N/A
EPS
0.02
N/A
Revenue
$49,060,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2,020.50
N/A
Revenue Growth
4.23
N/A
52 Week Low
$31.48
$5.80
52 Week High
$59.65
$19.40

Technical Indicators

Market Signals
Indicator
TCI
TENX
Relative Strength Index (RSI) 46.74 46.84
Support Level $34.92 $12.84
Resistance Level $42.02 $16.35
Average True Range (ATR) 1.79 1.21
MACD -0.79 -0.33
Stochastic Oscillator 37.10 4.81

Price Performance

Historical Comparison
TCI
TENX

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates in two business segments: the acquisition, development, ownership and management of multifamily properties; and the acquisition, development, ownership and management of commercial properties; which are office properties. The services for its commercial segment include rental of office space and other tenant services, including parking and storage space rental. The services for its multifamily segment include rental of apartments and other tenant services, including parking and storage space rental. the company derives maximum revenue from Multifamily Segment.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: